Coronavirus: Emergency Grant Aid promoting COVID-19 vaccination in Latin American and the Caribbean and African countries
On February 25, the Government of Japan decided to extend Emergency Grant Aid of 30 million US dollars to Latin American and the Caribbean and African countries that suffer from the impact of Novel Coronavirus Disease (COVID-19).
- This assistance will provide 17 countries in the Latin America and the Caribbean and African regions with cold chain equipment including medical equipment such as cold-storage facilities and the capacity building assistance for promoting vaccination in each country, among others, as “Last One Mile Support” through the United Nations Children’s Fund (UNICEF).
- In order to overcome COVID-19, it is important to ensure and promote equitable access to vaccines throughout the world.Japan will continue to make its contributions in order to supply vaccines and strengthen the delivery and vaccination capacities including through “Last One Mile Support” and assistance via the COVAX Facility.
(Recipient countries)
(Latin America and the Caribbean: 7 countries)
Ecuador, El Salvador, Colombia, Dominican Republic, Belize, Bolivia, Honduras
(Africa: 10 countries)
Botswana, Gabon, Gambia, Guinea-Bissau, Lesotho, Namibia, Niger, South Africa, Tanzania, TogoDistributed by APO Group on behalf of Ministry of Foreign Affairs of Japan.
Send us your press releases to [email protected]
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages
